166815-96-9

Basic information

• Product Name: N-TERT-BUTOXYCARBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE
• Synonyms: 4-[(4-methylphenyl)sulfonyloxymethyl]-1-piperidinecarboxylic acid tert-butyl ester;4-[(4-methylphenyl)sulfonyloxymethyl]piperidine-1-carboxylic acid tert-butyl ester;tert-Butyl 4-((tosyloxy);N-TERT-BUTOXYCARBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE;1-PIPERIDINECARBOXYLIC ACID, 4-[[[(4-METHYLPHENYL)SULFONYL]OXY]METHYL]-, 1,1-DIMETHYLETHYL ESTER;N-tert-Butoxycarbonyl-4-(4-toluenesulfonyloxymethyl)piperidine95%;N-tert-Butoxycarbonyl-4-(4-toluenesulfonyloxymethyl);N-Boc-4-(4-toluenesulfonyloxymethyl)piperidine
• CAS NO: 166815-96-9
• Molecular Formula: C₁₈H₂₇NO₅S
• Molecular Weight: 369.48
• Mol File: 166815-96-9.mol
• Article Data: 45

Chemical Properties

• Melting Point: 74-76℃
• Boiling Point: 487.784 °C at 760 mmHg
• Flash Point: 248.803 °C
• Appearance: /
• Density: 1.175 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.526
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• PKA: -1.94±0.40(Predicted)
• CAS DataBase Reference: N-TERT-BUTOXYCARBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: N-TERT-BUTOXYCARBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE(166815-96-9)
• EPA Substance Registry System: N-TERT-BUTOXYCARBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE(166815-96-9)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 166815-96-9(Hazardous Substances Data)

Usage

Description

N-TERT-BUTOXYCARBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE, also known as tert-Butyl 4-((tosyloxy)methyl)piperidine-1-carboxylate, is a chemical compound that serves as an intermediate in the synthesis of biologically active molecules. It is characterized by its structural complexity and potential for use in the development of pharmaceuticals with various applications.

Uses

Used in Pharmaceutical Industry:
N-TERT-BUTOXYCARBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE is used as a chemical intermediate for the preparation of biologically active molecules with pharmacological applications. Its unique structure allows for the creation of compounds that can target specific biological pathways, potentially leading to the development of new drugs for various medical conditions.
As a key component in the synthesis of pharmaceuticals, N-TERT-BUTOXYCARBONYL-4-(4-TOLUENESULFONYLOXYMETHYL)PIPERIDINE plays a crucial role in advancing the field of drug discovery and development. Its versatility in chemical reactions enables researchers to explore a wide range of potential applications, from treating chronic diseases to addressing pressing health concerns.

InChI:InChI=1/C18H27NO5S/c1-14-5-7-16(8-6-14)25(21,22)23-13-15-9-11-19(12-10-15)17(20)24-18(2,3)4/h5-8,15H,9-13H2,1-4H3

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 123855-51-6 tert-butyl 4-(hydroxymethyl)piperidin-1-carboxylate 
• 6457-49-4 4-piperidinemethanol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 280-57-9 1,4-diaza-bicyclo[2.2.2]octane 
• 107-83-5 2-Methylpentane 
• 84358-13-4 N-[(tert-butoxy)carbonyl]piperidine-4-carboxylic acid 
• 104-15-4 toluene-4-sulfonic acid 

Downstream Products

• 259143-03-8 tert-butyl 4-(fluoromethyl)piperidine-1-carboxylate 
• 338992-20-4 4-(((4-((4-bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-yl)oxy)methyl)piperidine-1-carboxylic acid tert-butyl ester 
• 906565-52-4 methyl 3-methoxy-4-(1-tert-butyloxycarbonylpiperidin-4-ylmethoxy)benzoate 
• 896125-05-6 4-[4-(3-nitrophenyl)piperazin-1-ylmethyl]piperidine-1-carboxylic acid tert-butyl ester 
• 1018894-91-1 tert-butyl 4-((4-amino-3-nitrophenoxy)methyl)piperidine-1-carboxylate 
• 1018896-02-0 tert-butyl 4-((3-methyl-4-nitrophenoxy)methyl)piperidine-1-carboxylate 
• 740873-60-3 3-{4-[1-(propane-2-sulfonyl)piperidin-4-ylmethyl]piperazin-1-yl}phenylamine 
• 740873-59-0 1-(3-nitrophenyl)-4-[1-(propane-2-sulfonyl)piperidin-4-ylmethyl]-4-piperazine 
• 896125-06-7 N-(3-{4-[1-(propane-2-sulfonyl)piperidin-4-ylmethyl]piperazin-1-yl}phenyl)acetamide 
• 740873-49-8 3-{4-[1-(4-fluorobenzenesulfonyl)piperidin-4-ylmethyl]piperazin-1-yl}phenylamine 
• 740873-48-7 1-[1-(4-fluorobenzenesulfonyl)piperidin-4-ylmethyl]-4-(3-nitrophenyl)piperazine 
• 740873-50-1 N-(3-{4-[1-(4-fluorobenzenesulfonyl)piperidin-4-ylmethyl]piperazin-1-yl}phenyl)acetamide 
• 740873-63-6 3-[4-(1-cyclohexylmethanesulfonyl-piperidin-4-ylmethyl)piperazin-1-yl]phenylamine 
• 740873-62-5 1-(1-cyclohexylmethanesulfonyl-piperidin-4-ylmethyl)-4-(3-nitrophenyl)piperazine 

Relevant articles and documents

Synthesis and evaluation of amide, sulfonamide and urea-benzisoxazole derivatives as potential atypical antipsychotics

In this paper, we report the optimization of a series of novel, potential antipsychotic derivatives combining potent dopamine D2, D3 and serotonin 5-HT1A, 5-HT2A receptor affinities. The pharmacological features of compound 27 are a high affinity for dopamine D2, D3 and serotonin 5-HT1A, 5-HT2A receptors. Moreover it possesses low affinity for 5-HT2C and H1 receptors (to reduce the risk of obesity associated with chronic treatment) and hERG channels (to reduce the incidence of torsade des pointes). Furthermore, compound 27 inhibited apomorphine-induced climbing, MK-801-induced hyperactivity and DOI-induced head twitch without observable catalepsy at the highest dose tested in mice. Taken together, among the amide derivatives, we identified compound 27 as a potential antipsychotic lead candidate.

Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and Stimulator for Interferon Genes (STING) modulators as cancer immunotherapeutics

Substituted -3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and related compounds, which are useful as inhibitors of ENPP1; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the ENPP1.

Palladium-Catalyzed Atom-Transfer Radical Cyclization at Remote Unactivated C(sp3)?H Sites: Hydrogen-Atom Transfer of Hybrid Vinyl Palladium Radical Intermediates

A novel mild, visible-light-induced palladium-catalyzed hydrogen atom translocation/atom-transfer radical cyclization (HAT/ATRC) cascade has been developed. This protocol involves a 1,5-HAT process of previously unknown hybrid vinyl palladium radical intermediates, thus leading to iodomethyl carbo- and heterocyclic structures.